The natural history of coronary artery disease: does medical therapy improve the prognosis?
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy / Q000401:mortality; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017023:Coronary Angiography; D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality; D003645:Death, Sudden / Q000209:etiology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality; D011379:Prognosis; D011897:Random Allocation; D012306:Risk; D012907:Smoking; D013552:Swine; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D008055:Lipids; D014665:Vasodilator Agents